Semaglutide is typically started at a low dose and increased slowly over time to give the body a chance to adjust
The results of once daily administration of the peptide for 12 weeks showed that the drug tripled weight loss when compared to placebo and that the rate of weight loss remained steady during the trial period
Looking ahead, the market is expected to continue growing as breakthroughs in novel molecular designs, oral formulations, and dual-target drugs push the boundaries of GLP-1 drug innovation
Users with higher body fat percentages may use 8 mm at the abdomen, but should use a 45-degree angle to avoid going too deep
Because they have personally experienced a reduced desire for food, they are more likely to anticipate a decline in overall demand, translating into lower revenues and profitability expectations for restaurants, grocery stores, and food manufacturers